Furthermore, it was found that NAC-sensitive tumors had a higher TCR clonality compared to NAC-resistant tumors, and this clonal expansion of TILs, particularly the CD8+ T cells, is suggestive of anti-tumor reactivity, based on the NAC response. This evidence concerns the gene CD8A and neoplasm.